Blood tests could predict who gets severe COVID
NCT ID NCT04668170
First seen Mar 24, 2026 · Last updated May 17, 2026 · Updated 6 times
Summary
This study aimed to find early signs in the blood that could predict which COVID-19 patients would become severely ill. Researchers analyzed immune cells and inflammatory markers from 304 hospitalized patients and healthcare workers. The goal was to identify biomarkers that could help doctors tailor treatments more quickly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Bordeaux
Bordeau, 33000, France
-
University Hospital Toulouse
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.